Patrick J Mcenany Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Patrick J Mcenany is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 4.48 Million shares of CPRX, which is worth approximately $96.2 Million. The most recent transaction as insider was on Dec 06, 2022, when has been sold 12,133 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.48M

0% 3M change

8.71% 12M change

Total Value Held $96.2 Million

PATRICK J MCENANY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 06 2022	SELL Payment of exercise price or tax liability	-	12,133 Reduced 0.31%	3,921,307 Common Stock, par valu...
Dec 06 2022	BUY Exercise of conversion of derivative security	-	30,834 Added 0.78%	3,933,440 Common Stock, par valu...
Nov 21 2022	SELL Open market or private sale	$2,299,500 $15.33 p/Share	150,000 Reduced 3.7%	3,902,606 Common Stock, par valu...
Nov 21 2022	BUY Exercise of conversion of derivative security	$336,000 $2.24 p/Share	150,000 Added 3.57%	4,052,606 Common Stock, par valu...
Nov 18 2022	SELL Open market or private sale	$5,467,000 $15.62 p/Share	350,000 Reduced 8.23%	3,902,606 Common Stock, par valu...
Nov 18 2022	BUY Exercise of conversion of derivative security	$784,000 $2.24 p/Share	350,000 Added 7.6%	4,252,606 Common Stock, par valu...
Sep 14 2022	SELL Open market or private sale	$14,590,897 $15.41 p/Share	946,846 Reduced 19.52%	3,902,606 Common Stock, par valu...
Sep 13 2022	SELL Open market or private sale	$1,238,127 $15.33 p/Share	80,765 Reduced 1.64%	4,849,452 Common Stock, par valu...
Aug 19 2022	SELL Open market or private sale	$1,762,500 $14.1 p/Share	125,000 Reduced 2.47%	4,930,217 Common Stock, par valu...
Aug 19 2022	BUY Exercise of conversion of derivative security	$316,250 $2.53 p/Share	125,000 Added 2.41%	5,055,217 Common Stock, par valu...
Aug 18 2022	SELL Open market or private sale	$2,439,500 $13.94 p/Share	175,000 Reduced 3.43%	4,930,217 Common Stock, par valu...
Aug 18 2022	BUY Exercise of conversion of derivative security	$316,250 $2.53 p/Share	125,000 Added 2.45%	4,980,217 Common Stock, par valu...
Aug 18 2022	BUY Exercise of conversion of derivative security	$126,500 $2.53 p/Share	50,000 Added 0.99%	4,980,217 Common stock,. par val...
Dec 03 2021	SELL Payment of exercise price or tax liability	-	12,132 Reduced 0.25%	4,930,227 Common Stock, par valu...
Dec 03 2021	BUY Exercise of conversion of derivative security	-	30,833 Added 0.62%	4,942,359 Common Stock, par valu...
Aug 23 2021	SELL Open market or private sale	$464,308 $5.62 p/Share	82,617 Reduced 1.65%	4,911,526 Common Stock, par valu...
Aug 23 2021	BUY Exercise of conversion of derivative security	$374,400 $3.12 p/Share	120,000 Added 2.35%	4,994,143 Common Stock, par valu...
Aug 20 2021	SELL Open market or private sale	$298,969 $5.52 p/Share	54,161 Reduced 1.1%	4,874,143 Common Stock, par valu...
Aug 20 2021	BUY Exercise of conversion of derivative security	$249,600 $3.12 p/Share	80,000 Added 1.6%	4,928,304 Common Stock, par valu...
Aug 13 2021	SELL Open market or private sale	$383,816 $6.12 p/Share	62,715 Reduced 1.28%	4,848,304 Common Stock, par valu...
Aug 13 2021	BUY Exercise of conversion of derivative security	$312,000 $3.12 p/Share	100,000 Added 2.0%	4,911,019 Common Stock, par valu...
Dec 22 2020	SELL Payment of exercise price or tax liability	-	7,507 Reduced 0.16%	4,811,019 Common Stock, par valu...
Dec 22 2020	BUY Exercise of conversion of derivative security	-	30,833 Added 0.64%	4,818,526 Common Stock, par valu...
Sep 30 2020	BUY Open market or private purchase	$44,550 $2.97 p/Share	15,000 Added 0.31%	4,787,693 Common Stock, par valu...

PJM

Patrick J Mcenany

Director

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account